ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

Leigh Turner

doi:10.1016/j.stemcr.2021.05.011

ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

Stem Cell Reports. 2021 Jun 8;16(6):1394-1397. doi: 10.1016/j.stemcr.2021.05.011. Epub 2021 May 27.

Author

Leigh Turner¹

Affiliation

¹ University of Minnesota Center for Bioethics, School of Public Health, and College of Pharmacy, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.

Abstract

The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.

MeSH terms

Cell- and Tissue-Based Therapy / ethics
Cell- and Tissue-Based Therapy / standards*
Ethics, Research
Health Policy
Humans
Practice Guidelines as Topic*
Science / ethics
Science / standards*
Societies, Scientific / ethics
Societies, Scientific / standards*
Stem Cell Research / ethics*
Stem Cells
Translational Research, Biomedical / ethics
Translational Research, Biomedical / standards*